{"id":"tp-53255","type":"article-newspaper","title":"J&J’s JJDC Venture Arm Co-Leads Delix Therapeutics’ $100 Million Round","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53255","datePublished":"2026-11-10T17:54:48.000Z","dateModified":"2026-11-10T17:54:48.000Z","language":"en","abstract":"The financing will support Phase IIb proof-of-concept work for recurrent major depressive disorder and Delix’s broader neuroplastogen pipeline.","section":"Business","references":[]}